QX200™ Droplet Generator (1864002)
Droplet generator for EvaGreen or probe-based digital PCR applications, for use with QX200™ Droplet Digital™ PCR System

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Use the QX200 droplet generator to complete the first step of the Droplet Digital PCR (ddPCR™) workflow by partitioning ddPCR reaction mix into 20,000 nanoliter-sized droplets for up to 8 samples per run. The droplet generator is used with the QX200 droplet reader for EvaGreen or probe-based digital PCR applications.
Features
- Simplifies the ddPCR workflow Minimizes hands-on time Eliminates user-to-user variability
- Enables user-definable plate real estate in increments of 8 wells
- Guided quick load allows you to get started faster HEPA-filtered enclosure reduces contamination
- Full-color touch screen with simple user interface facilitates setup and tracking of plates
- Works with the QX100™ or QX200 droplet reader
For extended product descriptions and detail specification information, please visit Bio-Rad.com.
ddPCR™ Library Quantification Kit for Ion Torrent Enabling Accurate Library Quantification and Balancing of Pooled Libraries
This application note demonstrates the incorporation of Bio-Rad’s Droplet Digital™ PCR (ddPCR) system into the library preparation workflow, accurately quantifying and balancing libraries for Ion Torrent sequencing platforms. ddPCR provides highly precise measurements to quantify Ion Torrent libraries without the need for standards.
Everything you need to know about how to use Droplet Digital PCR
This comprehensive applications guide presents a variety of uses for the Droplet Digital™ PCR (ddPCR™) from Bio-Rad. Droplet Digital polymerase chain reaction was developed to provide high-precision, absolute quantification of nucleic acid target sequences with wide-ranging applications for both research and clinical diagnostic applications.
Clearance of Plasma EGFR Mutations as a Predictor of Outcome on Osimertinib in the AURA Trial
This poster presents an exploratory analysis into whether dynamic changes in the levels of plasma EGFR mutations post-osimertinib treatment are associated with clinical outcome. It presents data from the AURA Phase I study in patients with disease progression following prior therapy with an EGFR-TKI and T790M-positive baseline genotyping (in tumor tissue or plasma). It was found that early clearance of plasma EGFR mutations in patients receiving osimertinib therapy appears to be a prognostic marker for improved median progression-free survival of patients.
Detection of Rare Mutations in Blood Samples by Droplet Digital PCR
Detection and quantitation of specific mutations in circulating plasma holds promise for earlier and less invasive diagnosis of disease. Learn how a simple droplet digital PCR strategy can detect somatic mutations with high selectivity and sensitivity.
Discover Decisive Moments in Personalized Cancer Treatment
Learn how liquid biopsies are replacing solid biopsies and are increasing the speed of cancer diagnosis, improving outcomes for patients. Also, find out how liquid biopsy can be used to quantify and monitor mutation, enabling rapid decision-making and treatment plans.
Accelerating Cancer Genetics Research Using Digital PCR
Professor of Genetics, Diptasri Mandal and graduate student, Kirsten Wood, of the Department of Genetics at Louisiana State University Health Sciences Center, explain how custom digital PCR assays are facilitating their research into hereditary biomarkers of prostate cancer.
Using Digital PCR to Identify Cancer Biomarkers from Liquid Biopsies
Scientists at the New York University School of Medicine explain how digital PCR has enabled the identification of novel biomarkers of cancer from liquid biopsies. Digital PCR assists them in detecting and counting low amounts of cell-free DNA being investigated as a promising new biomarker for metastatic disease. Watch the video to learn more.
Droplet Digital™ PCR (ddPCR™) Precision Molecular Profiling of Cancer
In this webinar Dr Dawne Shelton discusses how Droplet Digital PCR (ddPCR) can be used to develop personalized cancer care by identifying cancer subtypes and optimizing drug treatment plans. Dr Shelton summarizes work covering the tracking of cell-free tumor DNA during patient progression of disease and treatment monitoring, early detection of tumor cfDNA in blood, detection of copy number amplifications of common genes like MYC, HER2, and EGFR, as well as the detection of KRAS mutations using a multiplex screening strategy.
Digital PCR Using the Bio-Rad QX100™ ddPCR™ System
In this video Bio-Rad Laboratories showcase the QX100™ Droplet Digital™ PCR (ddPCR™) system, which provides an absolute measure of target DNA molecules with unrivaled performance in precision, accuracy, and sensitivity for quantitative PCR applications. The Droplet Digital PCR system is the third generation of PCR technology and provides a revolutionary approach to target DNA quantification.
Using Droplet Digital™ PCR to Monitor Environmental Contaminants in Water
In this video, researchers Yiping Cao and John Griffith of the Southern California Coastal Water Research Project (SCCWRP) describe their work using Bio-Rad's Droplet Digital PCR (ddPCR™) platform to determine variations in water quality from coastal watersheds to the ocean. Environmental monitoring for genetic targets such as pathogens, invasive species, or other biological activity requires the ability to detect small target concentrations within complex, non-uniform samples.
Automated Droplet Generator Simplifies Droplet Digital PCR Workflow
Discover how Bio-Rad’s Automated QX200™ Droplet Generator can generate a full 96 well plate from your samples in less than 30 mins, reducing hands-on time, simplifying your workflow, and increasing data reproducibility. Also, learn how the QX200™ Droplet Digital™ PCR System now supports EvaGreen chemistry applications, offering users more flexibility. Interview filmed by SelectScience at AACR 2014.
Cancer Mutation Profile in 72 Hours with Simple Blood Test
Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test
Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic
The first digital PCR instrument with the CE IVD mark
miRNAs as Cancer Biomarkers: Overcoming the Challenges of Quantifying Free-Circulating miRNA
Advances in biomarker research using Droplet Digital™ PCR





























